3 IP Lessons From The 2025 LF Dealmakers Forum
The LF Dealmakers Forum reminds us of the need to stay vigilant, knowledgeable about the rules of the game, and flexible enough to adapt to policy decisions.
Texas Holds A Litigation Funding Conference Flush In 2026
The current patent litigation funding market is a lot like a cup of coffee.
Stand With Survivors: Legal Tools To Make A Real Difference This DVAM
Enhance your legal skills to advocate for survivors of intimate partner violence.
3 Questions For A Law Firm Marketing Professional (Part I)
The confidential nature of the work done by IP attorneys adds complexity to marketing their achievements.
3 (IP) Takeaways From The Lex Machina 2025 Litigation Damages Report
The report’s presentation of data shows that modern patent litigation remains a vibrant and challenging pursuit for both plaintiffs and defendants.
Exacting Nexus Standard
The introduction of Cologuard after FDA-approval in 2014 has been a gamechanger in colon cancer diagnosis.
3 Questions For Another Court Access Crusader (Part II)
There is no doubt in my mind that Free Law Project’s tools are a must-add to any aspiring federal court litigator’s toolbox.
What Your Clients Say When They Know You Won’t Hear It
Download this 63-page survey report and get the truth about the legal client experience.
3 Questions For Another Court Access Crusader (Part I)
The RECAP Archive gets a major enhancement.
3 Takeaways From The Lex Machina 2025 Patent Report
Modern patent litigation remains a vibrant and challenging pursuit for both plaintiffs and defendants.
Patenting Privation (Part III): Empowering Revenge
Much like America's waistline, a dispute between Eli Lilly and a large compounder called Empower Pharmacy is expanding.
Into The Sun: Federal Circuit Provides Clarity On The Role Of Injunctions In Pharma Cases
An interesting scenario where the limited lifespan of a patent renders it less effective as a means of keeping out a competitive product from the market.
Chrometa: Turning Time Into Billable Value For Modern Lawyers
Adoption of Chrometa represents more than a technological upgrade; it reflects a professional philosophy that values accuracy, transparency, and efficiency.
3 Questions For A Tech Entrepreneur Turned Chinese Patent Enforcer (Part II)
Thoughts from a tech leader who stands as Microsoft's formidable opponent in a landmark patent infringement case in China.
3 Questions For A Tech Bro Turned Chinese Patent Enforcer (Part I)
Matthew Allan Newman shares his experiences navigating the Chinese IP landscape.
Nobody Beats The Wiz
Ultimately, the proposed purchase of Wiz by Google raises the potential value of the patent lawsuit even higher to the parties, making the case even more worthy of our attention going forward.
Sculpting A Copyright Do-Over
As a bonus, the opinion answers some pressing questions on one of the hottest topics in copyright law today.
3 Questions For A College Athlete Turned Birdie Girl (Part II)
When confronted with an unplanned business crisis, it is important to lean on trusted advisors.